Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tinavi Medical Technologies Co (SHSE:688277) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Tinavi Medical Technologies Co EBITDA Margin % Related Terms
Tinavi Medical Technologies Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tinavi Medical Technologies Co EBITDA Margin % Chart
SHSE:688277 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Tinavi Medical Technologies Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tinavi Medical Technologies Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tinavi Medical Technologies Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Tinavi Medical Technologies Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tinavi Medical Technologies Co (SHSE:688277) has a EBITDA Margin % of -91.53% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tinavi Medical Technologies Co and its competitors. According to the industry distribution chart, Tinavi Medical Technologies Co ranks #656 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 80.5%.
Is Tinavi Medical Technologies Co's EBITDA Margin % too high?
Tinavi Medical Technologies Co's current EBITDA Margin % is -91.53%. Based on the distribution chart, Tinavi Medical Technologies Co ranks #656 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tinavi Medical Technologies Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tinavi Medical Technologies Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tinavi Medical Technologies Co ranks #656 out of 815 companies for EBITDA Margin %. This places Tinavi Medical Technologies Co in the lower half of its industry. The industry median EBITDA Margin % is 7.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tinavi Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tinavi Medical Technologies Co's current EBITDA Margin % is -91.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tinavi Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tinavi Medical Technologies Co (SHSE:688277) is currently considered Fairly Valued. The stock's GF Value™ is ¥19.55, compared to a current price of ¥19.09 — trading 2.4% below its estimated fair value. The current EBITDA Margin % is -91.53%. Tinavi Medical Technologies Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tinavi Medical Technologies Co (SHSE:688277), the current EBITDA Margin % is -91.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tinavi Medical Technologies Co (SHSE:688277) Overvalued in 2026?
Based on GuruFocus' analysis, Tinavi Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥19.09 is trading 2.4% below its estimated GF Value™ of ¥19.55.
GuruFocus considers Tinavi Medical Technologies Co to be Fairly Valued.
Key valuation signals for SHSE:688277:
EBITDA Margin %: -91.53%
GF Value™: ¥19.55 vs. price of ¥19.09 (2.4% below fair value)
No single metric tells the full story. See the SHSE:688277 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tinavi Medical Technologies Co Business Description
AddressJianfeng Road South Extension, Building 2, Courtyard 8, Jinyu Science and Technology Park, Zhongguancun Xisanqi, Haidian District, Beijing, CHN, 100096
Tinavi Medical Technologies Co Ltd is engaged in the Research, development, production, sales and service of orthopedic surgical navigation and positioning robots.
74GF Score
Get the complete analysis for SHSE:688277
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688277 has been successfully added to your 
